Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TYMS antibody

TYMS Reactivity: Human IF, IHC Host: Mouse Monoclonal TYSY9 unconjugated
Catalog No. ABIN6252273
  • Target See all TYMS Antibodies
    TYMS (Thymidylate Synthetase (TYMS))
    Reactivity
    • 92
    • 28
    • 13
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Host
    • 49
    • 41
    • 2
    Mouse
    Clonality
    • 48
    • 44
    Monoclonal
    Conjugate
    • 46
    • 7
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This TYMS antibody is un-conjugated
    Application
    • 51
    • 42
    • 35
    • 22
    • 19
    • 19
    • 19
    • 17
    • 14
    • 13
    • 11
    • 7
    • 7
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Immunofluorescence (IF), Immunohistochemistry (IHC)
    Purification
    Protein G purified monoclonal antibody
    Immunogen
    Recombinant human protein was used as the immunogen for this Thymidylate synthase antibody.
    Clone
    TYSY9
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product TYMS Primary Antibody
  • Application Notes
    Immunofluorescence: 0.5-1 μg/mL

    IHC (FFPE): 0.5-1 μg/mL for 30 minutes at RT (1)

    Prediluted format : incubate for 30 min at RT (2)

    The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Thymidylate synthase antibody to be titered up or down for optimal performance.

    1. Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10  mM Citrate Buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.2 mg/mL
    Buffer
    PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Aliquot and Store at -20C. Avoid freez-thaw cycles.
  • Target
    TYMS (Thymidylate Synthetase (TYMS))
    Alternative Name
    Thymidylate Synthase (TYMS Products)
    Synonyms
    FN1 antibody, ECK2823 antibody, JW2795 antibody, ts antibody, Ts antibody, HST422 antibody, TMS antibody, TS antibody, thymidylate synthetase antibody, contains intron in T4 phage antibody, ThyE antibody, thymidylate synthase antibody, thymidylate synthetase L homeolog antibody, TYMS antibody, thyA antibody, td antibody, thyE antibody, DDA3937_RS04960 antibody, tyms.L antibody, XBJ1_RS15770 antibody, EAMY_RS20680 antibody, Tyms antibody
    Target Type
    Viral Protein
    Background
    Thymidylate synthase converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is essential for DNA biosynthesis. Thymidylate synthase is also a critical target for the fluoropyrimidines, an important group of anti-neoplastic drugs that are widely used in the treatment of solid tumors. Both 5-FU and fluorodeoxyuridine are converted in tumor cells to FdUMP which inactivates thymidylate synthase by formation of a ternary covalent complex in the presence of the folate cofactor 5,10-methylenetetrahydrofolate. Expression of thymidylate synthase protein is associated with response to 5-fluorouracil (5-FU) in human colorectal, gastric, head and neck, and breast carcinomas.
    Gene ID
    7298
    UniProt
    P04818
    Pathways
    Mitotic G1-G1/S Phases
You are here:
Support